Mozambique

Reimbursed Care Access

Mozambique regulates narcotics and psychotropic substances under a domestic drug control law that implements international conventions (Law No. 3/97 and implementing decrees). Ketamine is used and regulated as an essential anesthetic in clinical settings, but newer marketed psychedelic medicines (esketamine/Spravato, psilocybin, MDMA, etc.) have no registered, reimbursed medical programs and remain either strictly controlled or only accessible within approved research. Most classic psychedelic compounds are explicitly controlled under Mozambique's scheduling framework with no routine medical reimbursement outside sanctioned clinical research.